Medication Can't Do It All, Says Obesity and Weight Management Expert

"These [antiobesity] agents are meant to be used to help patients with a healthy lifestyle. They work best and long-term if patients also receive education on the essentials of a healthy diet and physical activity."

In a recent conversation with Patient Care,® obesity and weight management expert Caroline Apovian, MD, emphasized for primary care clinicians that GLP-1 receptor agonists when used for chronic weight management should be paired with patient counseling for an optimal outcome.

Caroline M Apovian, MD, is a professor of medicine a Harvard Medical School and codirector of the Center for Weight Management and Wellness in the division of endocrinology, diabetes, and hypertension at Brigham and Women's Hospital in Boston, MA. Apovian is one of the founding creators of the American Board of Obesity Medicine, the body that provides certification and recognititon for physicains who have specialized knowledge and training in the practice of obesity medicine.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
© 2023 MJH Life Sciences

All rights reserved.